Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Wyeth’s Viviant “Approvable” For Osteoporosis

May 23 2008

• By Jessica Merrill

Related Content

Pfizer Files Lasofoxifene NDA For Treatment Of Osteoporosis

Jan 15 2008

Wyeth’s Viviant Receives Second “Approvable” Letter For Osteoporosis Prevention

Dec 28 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window